Table 13.
Analysis of multiple drug resistance rate of ESBLs-KPN in 2017.
| Drugs | Drug resistance rate (%) | |
|---|---|---|
| ESBLs-KPN | Ertapenem | 1.8 |
| Imipenem | 2.8 | |
| Piperacillin-tazobactam | 8 | |
| Amikacin | 9.7 | |
| Cefoperazone-sulbactam | 21.7 | |
| Tobramycin | 27.8 | |
| Gentamicin | 40.9 | |
| Fosfomycin | 42.3 | |
| Nitrofurantoin | 48.3 | |
| Levofloxacin | 49.4 | |
| Cefepime | 50 | |
| Ciprofloxacin | 60.8 | |
| Ceftazidime | 63.1 | |
| Aztreonam | 73.9 | |
| Cotrimoxazole | 80.7 | |
| Ampicillin-sulbactam | 90.3 | |
| Ceftriaxone | 99.4 | |
| Ampicillin | 100 |